OBJECTIVES: To identify predictors of becoming a daily cigarette smoker over the course of 4 years. METHODS: We identified 12- to 24-year-olds at wave 1 of the US Population Assessment of Tobacco and Health Study and determined ever use, age at first use, and daily use through wave 4 for 12 tobacco products. RESULTS: Sixty-two percent of 12- to 24-year-olds (95% confidence interval [CI]: 60.1% to 63.2%) tried tobacco, and 30.2% (95% CI: 28.7% to 31.6%) tried ≥5 tobacco products by wave 4. At wave 4, 12% were daily tobacco users, of whom 70% were daily cigarette smokers (95% CI: 67.4% to 73.0%); daily cigarette smoking was 20.8% in 25- to 28-year-olds (95% CI: 18.9% to 22.9%), whereas daily electronic cigarette (e-cigarette) vaping was 3.3% (95% CI: 2.4% to 4.4%). Compared with single product triers, the risk of progressing to daily cigarette smoking was 15 percentage points higher (adjusted risk difference [aRD] 15%; 95% CI: 12% to 18%) among those who tried ≥5 products. In particular, e-cigarette use increased the risk of later daily cigarette smoking by threefold (3% vs 10%; aRD 7%; 95% CI: 6% to 9%). Daily smoking was 6 percentage points lower (aRD -6%; 95% CI: -8% to -4%) for those who experimented after age 18 years. CONCLUSIONS: Trying e-cigarettes and multiple other tobacco products before age 18 years is strongly associated with later daily cigarette smoking. The recent large increase in e-cigarette use will likely reverse the decline in cigarette smoking among US young adults.
OBJECTIVES: To identify predictors of becoming a daily cigarette smoker over the course of 4 years. METHODS: We identified 12- to 24-year-olds at wave 1 of the US Population Assessment of Tobacco and Health Study and determined ever use, age at first use, and daily use through wave 4 for 12 tobacco products. RESULTS: Sixty-two percent of 12- to 24-year-olds (95% confidence interval [CI]: 60.1% to 63.2%) tried tobacco, and 30.2% (95% CI: 28.7% to 31.6%) tried ≥5 tobacco products by wave 4. At wave 4, 12% were daily tobacco users, of whom 70% were daily cigarette smokers (95% CI: 67.4% to 73.0%); daily cigarette smoking was 20.8% in 25- to 28-year-olds (95% CI: 18.9% to 22.9%), whereas daily electronic cigarette (e-cigarette) vaping was 3.3% (95% CI: 2.4% to 4.4%). Compared with single product triers, the risk of progressing to daily cigarette smoking was 15 percentage points higher (adjusted risk difference [aRD] 15%; 95% CI: 12% to 18%) among those who tried ≥5 products. In particular, e-cigarette use increased the risk of later daily cigarette smoking by threefold (3% vs 10%; aRD 7%; 95% CI: 6% to 9%). Daily smoking was 6 percentage points lower (aRD -6%; 95% CI: -8% to -4%) for those who experimented after age 18 years. CONCLUSIONS: Trying e-cigarettes and multiple other tobacco products before age 18 years is strongly associated with later daily cigarette smoking. The recent large increase in e-cigarette use will likely reverse the decline in cigarette smoking among US young adults.
Authors: Kristie A Taylor; Eva Sharma; Kathryn C Edwards; Michael J Halenar; Wendy Kissin; Karin A Kasza; Hannah Day; Gabriella Anic; Lisa D Gardner; Hoda T Hammad; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland; Cassandra Stanton Journal: Tob Control Date: 2020-05 Impact factor: 7.552
Authors: Jessica L King; David Reboussin; Jennifer Cornacchione Ross; Kimberly D Wiseman; Kimberly G Wagoner; Erin L Sutfin Journal: J Adolesc Health Date: 2018-08-13 Impact factor: 5.012
Authors: Blair N Coleman; Brian Rostron; Sarah E Johnson; Bridget K Ambrose; Jennifer Pearson; Cassandra A Stanton; Baoguang Wang; Cristine Delnevo; Maansi Bansal-Travers; Heather L Kimmel; Maciej L Goniewicz; Raymond Niaura; David Abrams; Kevin P Conway; Nicolette Borek; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2017-06-17 Impact factor: 7.552
Authors: David R Strong; Eric Leas; Tara Elton-Marshall; Olivia A Wackowski; Mark Travers; Maansi Bansal-Travers; Andrew Hyland; Martha White; Madison Noble; K Michael Cummings; Kristie Taylor; Annette R Kaufman; Kelvin Choi; John P Pierce Journal: Prev Med Date: 2019-03-13 Impact factor: 4.018
Authors: Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton Journal: Tob Control Date: 2016-08-08 Impact factor: 7.552
Authors: Blair N Coleman; Sarah E Johnson; Greta K Tessman; Cindy Tworek; Jennifer Alexander; Denise M Dickinson; Jessica Rath; Kerry M Green Journal: Drug Alcohol Depend Date: 2015-12-09 Impact factor: 4.492
Authors: Andrea S Gentzke; MeLisa Creamer; Karen A Cullen; Bridget K Ambrose; Gordon Willis; Ahmed Jamal; Brian A King Journal: MMWR Morb Mortal Wkly Rep Date: 2019-02-15 Impact factor: 17.586
Authors: Maciej L Goniewicz; Danielle M Smith; Kathryn C Edwards; Benjamin C Blount; Kathleen L Caldwell; Jun Feng; Lanqing Wang; Carol Christensen; Bridget Ambrose; Nicolette Borek; Dana van Bemmel; Karen Konkel; Gladys Erives; Cassandra A Stanton; Elizabeth Lambert; Heather L Kimmel; Dorothy Hatsukami; Stephen S Hecht; Raymond S Niaura; Mark Travers; Charles Lawrence; Andrew J Hyland Journal: JAMA Netw Open Date: 2018-12-07
Authors: Akash Patel; Jana L Hirschtick; Steven Cook; Bukola Usidame; Ritesh Mistry; David T Levy; Rafael Meza; Nancy L Fleischer Journal: Int J Environ Res Public Health Date: 2021-07-22 Impact factor: 3.390